Closing of capiton VI fund

capiton successfully closes fund VI at €504 million

  • Largest fund in the company’s history
  • Approximately €260 million, including co-investment, already deployed in seven portfolio companies
  • Fund to continue successful deployment in capiton’s focus sectors Pharmaceuticals, Medical Technology, Industrial Technology and Responsible Consumption

 

Berlin, 24 November 2021 – capiton AG (“capiton”), a leading owner-managed private equity firm in Germany, today announced the successful closing of its fund capiton VI, the firm’s largest to date. Commitments from a diverse investor base totaling €504 million enable capiton to continue its proven sector-focused investment approach of pro-actively sourced primary deals in the German-speaking region.

“The successful closing of our sixth and yet largest fund represents an important milestone in capiton’s long-standing history,” said Manuel Hertweck, Managing Partner and Board Member of capiton. “It is a testament to our strong track record, expertise in our defined sectors and outstanding reputation amongst entrepreneurs who seek a partner to take their business to the next level. On behalf of the capiton management team, I would like to thank our high-quality pool of existing and new investors for their trust and commitment. With the capital raised for capiton VI, we will continue to follow our successful investment strategy of acquiring majority and minority interests in leading mid-market firms, helping them realize their full potential and creating long-term value with a strong emphasis on ESG.”

capiton VI was subscribed to by a diverse group of investors entirely virtually including a strong re-up rate of long-standing existing investors as well as new blue-chip institutional investors. The fund will invest in majority and minority holdings with a focus on primary transactions in the targeted high-growth sectors of Pharmaceuticals, Medical Technology, Industrial Technology and Responsible Consumption. Upon closing, capiton VI has already committed 36% of its fund volume for platform investments in seven portfolio companies.

capiton’s key assets are its long history and experience in the Mittelstand in the DACH region – with more than 85% of all transactions sourced directly from owners – and a diverse investment team, composed of senior and long-tenured professionals as well as a growing pool of young investment talent. The firm is committed to growing its investment team and to retain and develop exceptional talent from within.

Lazard acted as placement agent, and Pöllath + Partner as legal counsel for capiton VI.

Pressemitteilungen

capiton acquires a stake in Solvis, a sustainable heating pioneer, backing the members of the management team which remain significant shareholders in the company. Solvis is headquartered in Braunschweig, Germany. The company was founded in 1982 and retains its operations in a factory which has been inaugurated as the first zero-emission-facility in Germany in 2002. […]

BIOGGIO, SWITZERLAND – October 4, 2021 – The KD Pharma Group has acquired a 51% stake in Trigal Pharma, a company specialized in clinical research, development and marketing of medical cannabinoids, such as Cannabidiol (CBD) in a highly-purified form. “Trigal has successfully and profitably grown by being a first mover in the API market for […]

capiton acquires the majority stake in Kutterer Mauer AG, backing one of the founders, Mr. Mauer in continuing the growth story of the company. Mr. Mauer as well as other management members invest alongside capiton. Kutterer Mauer AG is a globally operating manufacturer of caps and closure solutions with >450 employees. The Group designs and […]

capiton has successfully closed a new top-up single-asset fund for its fast-growing portfolio company KD Pharma Group („KD Pharma“). This top-up fund will provide KD Pharma with the equity financing for a number of additional strategic investments, in particular add-on acquisitions as well as organic growth initiatives to transfer KD Pharma‘s unique technology and service […]

We are delighted to announce the successful acquisition of 4PICO Litho by Raith. Raith, the leading global manufacturer of precision technology for nanofabrication instrumentation, has expanded its product offering by adding direct write laser lithography systems – manufactured by 4PICO Litho – to its business strategy. In 2004 4PICO Litho, located near Eindhoven (NL) started […]

capiton acquires majority stake in Stürtz Group. Stürtz Group, headquartered in Neustadt (Wied), Germany, is a market-leading designer, producer, and marketer of automated solutions for the window production industry across the globe. The company generated approximately EUR 46 million in sales in 2020 and employs around 270 FTEs across five locations globally. Stürtz’ product portfolio […]

Dec Group acquires Extract Technology We are delighted to announce the successful acquisition of Extract Technology by Dec Group. Extract Technology is a leading provider of containment and aseptic systems for the pharmaceutical, biotech, nuclear and chemical markets. Extract is headquartered in Huddersfield (UK) with a second facility in New Lisbon (US), serving the fast-growing […]

capiton acquires majority stake in Axxence Group The management team of the Axxence Group acquires in a MBO along with capiton the leading natural aroma chemicals manufacturer from its founder, Joost van Neck. Axxence Group, headquartered in Emmerich, Germany, is a leading manufacturer and supplier of natural aroma chemicals (NACs) for the global flavour & […]

EVP Group acquires Group Korott We are delighted to announce the successful acquisition of Group Korott by EVP Group. Group Korott is a leading manufacturer and distributor of vitamins, minerals, natural cosmetics, as well as sport supplements for the Spanish consumer healthcare market. In addition to its store-brand partnering business, Korott has its own brand […]

Engelmann, with headquarters in Wiesloch, Germany, is the leading European manufacturer of smart heat meters for the sub-metering industry.

Wundex Group, with headquarters in Senden, Germany, is a leading home care provider for patients with chronic wounds. The company‘s qualified wound managers provide home care services that enable faster and more effective wound treatment and significantly reduce the workload of general care providers and physicians, backed by an integrated digital platform.

Die Cedes AG („Cedes“) mit Sitz in Landquart (Schweiz) ist ein führendes Sensortechnologie Unternehmen in der Aufzugs- und Türenindustrie. Unter Verwendung von Infrarot- und Bildverarbeitungstechnologie werden die Produkte für die Automatisierung von Aufzügen, Rolltreppen und Eingängen eingesetzt. Cedes wurde 1986 gegründet und erwirtschaftete 2019 rund CHF 55 Mio. Umsatz mit rund 320 Mitarbeitern.